UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of May 2026
Commission File Number: 001-40303
Inspira Technologies Oxy B.H.N. Ltd.
(Translation of registrant’s name into
English)
2 Ha-Tidhar St.
Ra’anana 4366504, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form
20-F ☐ Form 40-F
CONTENTS
On May 1, 2026, Inspira Technologies
Oxy B.H.N. Ltd. (the “Company”) issued a press release titled “Inspira Secures $596,000 AME System Order from Leading
Irish Technological University,” a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form
6-K (this “Report”).
This Report is incorporated by
reference into the Company’s Registration Statements on Form F-3 (Registration Nos. 333-284308 and 333-289324) and Form S-8
(Registration Nos. 333-259057, 333-277980, 333-285565, 333-290162 and 333-292592), filed with the Securities and Exchange Commission,
to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently
filed or furnished.
| Exhibit No. |
|
|
| 99.1 |
|
Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on May 1, 2026,
titled “Inspira Secures $596,000 AME System Order from Leading Irish Technological University.” |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Inspira Technologies Oxy B.H.N. Ltd. |
| |
|
|
| Date: May 1, 2026 |
By: |
/s/ Dagi Ben-Noon |
| |
|
Name: |
Dagi Ben-Noon |
| |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
Inspira Secures $596,000 AME System Order
from Leading Irish Technological University
RA’ANANA, Israel, May 1, 2026 – Inspira Technologies Oxy
B.H.N. Ltd. (Nasdaq: IINN, IINNW) (“Inspira” or the “Company”) today announced that it has secured a $596,000 purchase
order for an Additively Manufactured Electronics (“AME”) system from a leading Irish technological research university. The
order is structured with a non-refundable upfront payment of 40% of the order value, which has been received by the Company, with the
balance payable against delivery.
The purchasing institution is a leading Irish technological research
university recognized for applied research and innovation in information and communications technologies, advanced communications systems,
secure digital infrastructure, photonic and quantum networking research, and next-generation industry-facing technology development. The
AME platform’s capacity to fabricate complex three-dimensional structures integrating conductive and dielectric materials at micron-level
precision is directly relevant to the customer’s research domains.
Beyond the system price, the order establishes a recurring revenue
stream from proprietary consumables, wear parts, and fixed annual service fees over the system’s operating lifetime. The recurring component
is structurally embedded in the platform’s operation, with consumable usage scaling to the customer’s research throughput. This combination
of upfront system revenue and lifetime recurring revenue is central to the commercial economics of Inspira’s AME business.
Inspira is scheduled to deliver and deploy the AME system in the
coming weeks, accompanied by advanced application training tailored for the university’s research teams. The Company expects the deployment
to serve as a reference installation supporting engagement with additional academic and commercial institutions across Europe and beyond.
About Inspira Technologies
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) is a technology company focused on solving the most critical physical and hardware
bottlenecks in quantum computing connectivity. Inspira develops unique quantum connectivity solutions designed for high-density, thermally
optimized operation in dilution cryostats, a prerequisite for scaling quantum systems beyond current physical limitations. Additionally,
the Company continues to advance its medical technology portfolio, including its respiratory support and blood monitoring platforms under
a dedicated business unit. For more information, please visit: www.q-trex.com and www.inspira-technologies.com.
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking
statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties
that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company
is using forward-looking statements when it discusses the benefits, advantages and capabilities of its AME system, that the order establishes
a recurring revenue stream from proprietary consumables, wear parts, and fixed annual service fees over the system’s operating lifetime,
the expected timing of the delivery and deployment of the AME system and advanced application training tailored for the university’s research
teams and that the Company expects the deployment to serve as a reference installation supporting engagement with additional academic
and commercial institutions across Europe and beyond. These forward-looking statements and their implications are based solely on the
current expectations of the Company’s management and are subject to a number of factors and uncertainties that could cause actual
results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company
undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting
the Company is contained under the heading “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal
year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the
SEC’s website at www.sec.gov.
Company Contact
Inspira Technologies
Email: info@inspirao2.com
Phone: +972-9-9664485
Investor Relations Contact
Arx Investor Relations
North American Equities Desk
inspira@arxhq.com
